John Boris

Analyst John Boris, carries an average stock price target met ratio of 60% that have a potential upside of 35.56% achieved within 563 days. Previously, John Boris worked at TRUIST.

John Boris’s has documented 62 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, Common Stock at 18-Dec-2018.

Wall Street Analyst John Boris

Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK) at 12/18/2018. The price target of $13 was fulfilled within 27 days with a profit of $2.91 (18.29%) receiving and performance score of 6.77.

Average potential price target upside

• of $61.47 (87.85%) on ABBV (ABBVIE).
• of $31.87 (45.59%) on LLY (ELI LILLY AND COMPANY).
• of $21.52 (46.84%) on MRK (MERCK MPANY).